Sumatriptan succinate

CAT: 0804-HY-B0121-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0804-HY-B0121-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Sumatriptan succinate (GR 43175) is an orally active 5-HT1 receptor agonist with IC50s of 7.3 nm, 9.3nm and 17.8 nm for 5-HT1D, 5-HT1B and 5-HT1F receptors, respectively. Sumatriptan succinate can be used for migraine headache research[1][2][3][4].
CAS Number
[103628-48-4]
Product Name Alternative
GR 43175 succinate
UNSPSC
12352005
Hazard Statement
H318
Target
5-HT Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Sumatriptan-succinate.html
Purity
99.89
Solubility
DMSO : 50 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL
Smiles
O=C(O)CCC(O)=O.O=S(CC1=CC2=C(NC=C2CCN(C)C)C=C1)(NC)=O
Molecular Formula
C18H27N3O6S
Molecular Weight
413.49
Precautions
H318
References & Citations
[1]S J Peroutka, et al. Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites. Eur J Pharmacol. 1989 Apr 12;163 (1) :133-6. |[2]K L Dechant, et al. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1992 May;43 (5) :776-98. |[3]Razzaque Z, et al. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation. Br J Clin Pharmacol. 1999 Jan;47 (1) :75-82.|[4]Bates EA, et al. Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice. Cephalalgia. 2010 Feb;30 (2) :170-8.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
5-HT1 Receptor; mLAG-3
Citation 01
Cell Rep Methods. 2023 Oct 23;3 (10) :100599.|J Headache Pain. 2024 Oct 30;25 (1) :187.|Mol Pharmacol. 2023 Nov;104 (5) :230-238.|Personalized Medicine Universe. 2019 May. |ACS Environ Au. 2025 Aug 8.|Anal Chem. 2025 Jun 3;97 (21) :11099-11109.

Related Products

CatalogName
HY-B0121BS-01Sumatriptan-d6 (succinate)
HY-B0121B-01Sumatriptan
HY-B0121ASumatriptan hydrochloride
HY-B0121BS1-01Sumatriptan-d6
HY-B0121BR-01Sumatriptan (Standard)
HY-B0121BS2Sumatriptan-d5
HY-144164SSumatriptan-d6 (hemisuccinate)
HY-B0121BS3Sumatriptan-d6 (formate)
HY-150205-01Succinate/succinate receptor antagonist 1
HY-135815A-01Mobocertinib (succinate)

Alternative Products

CatalogName
RM-S132000-01Sumatriptan Succinate
TRC-S810002-10MGSumatriptan-d6 Succinate
S8025-83Sumatriptan Succinate (3-[2- (Dimethylamino) ethyl]-N-methyl-1H-indole-5-methanesulfonamide, Succinate, Imigran, Imitrex, )
MBS6037166-01Sumatriptan Succinate (3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide, Succinate, Imigran, Imitrex,)
1592982-[[3-[2- (Dimethylamino) ethyl]-1H-indol-5-yl]methyl] Sumatriptan Succinate
S8025-83DSumatriptan-d6 Succinate (3-[2- (Dimethyl-d6-amino) ethyl]-N-methyl-1H-indole-5-methanesulfonamide, Succinate, Imigran, Imitrex, )
MBS6094862-01Sumatriptan-d6 Succinate (3-[2-(Dimethyl-d6-amino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide, Succinate, Imigran, Imitrex,)
1592992-[[3-[2- (Dimethylamino) ethyl]-1H-indol-5-yl]methyl] Sumatriptan Succinate-d6
TRC-D446672-500MG2-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl] Sumatriptan Succinate-d6
M33934-01Sumatriptan

Popular Products